Clinical Characteristics and Outcomes of Pediatric Patients with Confirmed or Suspected COVID-19 within a Large Public Hospital System

preprint OA: closed
View at publisher

Abstract

Background: Children mostly exhibit non-specific symptoms and are at a lower risk of severe disease from COVID-19. The objective of the study was to describe the demographic, clinical features, and outcomes of children, stratified by age, with a laboratory confirmed or suspected diagnosis of COVID-19.Methods: A cross-sectional study was conducted within a large safety-net public hospital system in Phoenix, Arizona, during the pandemic’s summer surge (March 15th – September 30th, 2020). Children (0-<18 years) undergoing molecular testing for SARS-CoV-2 were included. Detailed review of hospital records was done. The association between SARS-CoV-2 test positivity and presenting complaints were examined. Also, the relationship between hospitalization and demographic characteristics, COVID-19 test positivity, triage temperature, and primary discharge diagnosis was explored. Findings: 1,032 children underwent testing for the SARS-CoV-2 during the study period. Mean age was 9.7 (SD + 6.0) years, 50% were male, and majority were Hispanic (74%). Overall test positivity rate was 21.3%. Test positivity was significantly higher in children reporting Hispanic ethnicity or Asian racial background compared with other race/ethnic groups. Among children with an ED visit (N=369), there was no significant association between common presenting complaints and test positivity. However, in children with loss of taste and/or smell 83% tested positive for COVID-19. Pneumonia and Multisystem Inflammatory Syndrome in Children (MIS-C) significantly increased the likelihood of hospitalization (Pneumonia: OR, 7.6 [95% CI, 2.4-23.6]; MIS-C: OR, 46.8 [95% CI, 4.9-444.3]). No deaths were reported.Interpretation: COVID-19 has a milder disease manifestation in children with most cases managed in an outpatient setting. Loss of taste and/or smell is highly predictive of SARS-CoV-2 test positivity; however, test positivity is not predictive of a need for hospitalization.Funding: All phases of this study was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.Declaration of Interests: The authors have no conflicts of interest relevant to this article to disclose.Ethics Approval Statement: The study was approved by the Institutional Review Board of the Valleywise Health, Phoenix AZ.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00